Market Cap 22.21B
Revenue (ttm) 13.01B
Net Income (ttm) 746.00M
EPS (ttm) N/A
PE Ratio 16.81
Forward PE 16.29
Profit Margin 5.73%
Debt to Equity Ratio 0.58
Volume 1,154,900
Avg Vol 777,692
Day's Range N/A - N/A
Shares Out 82.90M
Stochastic %K 84%
Beta 0.91
Analysts Strong Sell
Price Target $300.53

Company Profile

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 336-584-5171
Fax: 336-436-1569
Address:
531 South Spring Street, Burlington, United States
PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:55 PM
$LH is currently trading at $266.89, showing a neutral market context with an RSI of 44.16, indicating it is neither overbought nor oversold. The price is below the 30-day moving average (MA30) of $269.94 and the 50-day moving average (MA50) of $273.28, suggesting a bearish short-term trend. The recent high of $293.72 and low of $244.52 over the last 60 days indicates a range-bound market, with potential for a rebound from the lower end. Directional bias leans bearish due to the price being below key moving averages and the RSI indicating room for downside movement. Suggested entry: $265.50 (below current price for confirmation of weakness). Stop loss: $271.00 (above MA30). Targets: $255.00 (near 60D low) and $250.00 (psychological support). Monitor for any changes in momentum or breakout patterns. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:29 AM
$LH is currently trading at $267.87, with an RSI of 42.54 indicating it is nearing oversold conditions, suggesting potential upward momentum. The price is below both the 30-day moving average (MA30) of 270.27 and the 50-day moving average (MA50) of 273.52, indicating a bearish trend in the short to medium term. However, the proximity to the 60-day low of 244.52 provides a support level that could attract buyers. Directional bias leans slightly bullish due to the RSI, but caution is warranted given the current price below key moving averages. Suggested entry point: $268.50, just above the last close to confirm upward movement. Set a stop loss at $264.00, below recent support levels. Target 1: $275.00, approaching the MA30. Target 2: $280.00, which is a psychological resistance level. Monitor price action closely to adjust strategy as necessary. https://privateprofiteers.com
0 · Reply
notreload_ai
notreload_ai Nov. 13 at 5:09 PM
$HIMS , $DGX , $LH ... Hims & Hers Health launches lab testing with Quest Diagnostics, offering affordable biomarker tests and personalized health plans as part of its preventive care expansion. https://notreload.xyz/hims-launches-affordable-lab-testing/
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:35 AM
$LH is currently trading at $267.35, with an RSI of 40.15 indicating it is approaching oversold territory, suggesting potential for upward movement. The price is below both the 30-day MA of 271.07 and the 50-day MA of 273.81, indicating a bearish short-term trend. However, the proximity to the 60-day low of 244.52 suggests a strong support level, while the 60-day high of 293.72 presents a significant resistance point. Given this context, a potential trade plan is as follows: Suggested Entry: $268.50, slightly above the last close to confirm upward momentum. Stop Loss: $262.00, below the recent support level. Target 1: $275.00, near the 30-day MA. Target 2: $280.00, a psychological level before reaching the 50-day MA. This plan capitalizes on potential recovery while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:12 AM
$LH is currently trading at $267.35, with an RSI of 40.15 indicating it is approaching oversold territory, suggesting potential for upward movement. The price is below both the 30-day MA of 271.07 and the 50-day MA of 273.81, indicating a bearish short-term trend. However, the proximity to the 60-day low of 244.52 suggests a strong support level, while the 60-day high of 293.72 presents a significant resistance point. Given this context, a potential trade plan is as follows: Suggested Entry: $268.50, slightly above the last close to confirm upward momentum. Stop Loss: $262.00, below the recent support level. Target 1: $275.00, near the 30-day MA. Target 2: $280.00, a psychological level before reaching the 50-day MA. This plan capitalizes on potential recovery while managing risk effectively. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 7:55 PM
JP Morgan updates rating for Labcorp Hldgs ( $LH ) to Overweight, target set at 291 → 317.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 4 at 3:24 PM
$LH Share Price: $253.91 Contract Selected: May 15, 2026 $250 Calls Buy Zone: $18.45 – $22.79 Target Zone: $30.26 – $36.98 Potential Upside: 55% ROI Time to Expiration: 191 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
allen02
allen02 Nov. 4 at 12:14 PM
$LH Bullish Three White Soldiers Candlestick Pattern.
0 · Reply
Halo202
Halo202 Nov. 2 at 9:57 PM
$LH $260+ by Friday
0 · Reply
Nosh
Nosh Nov. 1 at 7:10 AM
$LH Yah coming in on Monday with a starter....
0 · Reply
Latest News on LH
Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript

Oct 28, 2025, 12:31 PM EDT - 17 days ago

Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript


Labcorp Announces 2025 Third Quarter Results

Oct 28, 2025, 6:50 AM EDT - 17 days ago

Labcorp Announces 2025 Third Quarter Results


Labcorp Declares Quarterly Dividend

Oct 8, 2025, 4:15 PM EDT - 5 weeks ago

Labcorp Declares Quarterly Dividend


Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 2:38 PM EDT - 4 months ago

Labcorp Holdings Inc. (LH) Q2 2025 Earnings Call Transcript


Why Is Testing Giant Labcorp Stock Surging On Thursday?

Jul 24, 2025, 12:27 PM EDT - 4 months ago

Why Is Testing Giant Labcorp Stock Surging On Thursday?


Labcorp Announces 2025 Second Quarter Results

Jul 24, 2025, 6:50 AM EDT - 4 months ago

Labcorp Announces 2025 Second Quarter Results


Labcorp to Webcast Its Annual Meeting of Shareholders May 15

May 8, 2025, 4:15 PM EDT - 6 months ago

Labcorp to Webcast Its Annual Meeting of Shareholders May 15


Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 4:21 PM EDT - 7 months ago

Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript


Labcorp Announces 2025 First Quarter Results

Apr 29, 2025, 6:50 AM EDT - 7 months ago

Labcorp Announces 2025 First Quarter Results


Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 3:42 PM EST - 10 months ago

Labcorp Holdings Inc. (LH) Q4 2024 Earnings Call Transcript


Labcorp Announces 2024 Fourth Quarter and Full Year Results

Feb 6, 2025, 6:50 AM EST - 10 months ago

Labcorp Announces 2024 Fourth Quarter and Full Year Results


LABCORP DECLARES QUARTERLY DIVIDEND

Jan 8, 2025, 6:02 PM EST - 11 months ago

LABCORP DECLARES QUARTERLY DIVIDEND


Labcorp CFO Glenn Eisenberg Announces Plans to Retire

Nov 19, 2024, 7:00 AM EST - 1 year ago

Labcorp CFO Glenn Eisenberg Announces Plans to Retire

ONC


PrivateProfiteer
PrivateProfiteer Nov. 14 at 11:55 PM
$LH is currently trading at $266.89, showing a neutral market context with an RSI of 44.16, indicating it is neither overbought nor oversold. The price is below the 30-day moving average (MA30) of $269.94 and the 50-day moving average (MA50) of $273.28, suggesting a bearish short-term trend. The recent high of $293.72 and low of $244.52 over the last 60 days indicates a range-bound market, with potential for a rebound from the lower end. Directional bias leans bearish due to the price being below key moving averages and the RSI indicating room for downside movement. Suggested entry: $265.50 (below current price for confirmation of weakness). Stop loss: $271.00 (above MA30). Targets: $255.00 (near 60D low) and $250.00 (psychological support). Monitor for any changes in momentum or breakout patterns. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:29 AM
$LH is currently trading at $267.87, with an RSI of 42.54 indicating it is nearing oversold conditions, suggesting potential upward momentum. The price is below both the 30-day moving average (MA30) of 270.27 and the 50-day moving average (MA50) of 273.52, indicating a bearish trend in the short to medium term. However, the proximity to the 60-day low of 244.52 provides a support level that could attract buyers. Directional bias leans slightly bullish due to the RSI, but caution is warranted given the current price below key moving averages. Suggested entry point: $268.50, just above the last close to confirm upward movement. Set a stop loss at $264.00, below recent support levels. Target 1: $275.00, approaching the MA30. Target 2: $280.00, which is a psychological resistance level. Monitor price action closely to adjust strategy as necessary. https://privateprofiteers.com
0 · Reply
notreload_ai
notreload_ai Nov. 13 at 5:09 PM
$HIMS , $DGX , $LH ... Hims & Hers Health launches lab testing with Quest Diagnostics, offering affordable biomarker tests and personalized health plans as part of its preventive care expansion. https://notreload.xyz/hims-launches-affordable-lab-testing/
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:35 AM
$LH is currently trading at $267.35, with an RSI of 40.15 indicating it is approaching oversold territory, suggesting potential for upward movement. The price is below both the 30-day MA of 271.07 and the 50-day MA of 273.81, indicating a bearish short-term trend. However, the proximity to the 60-day low of 244.52 suggests a strong support level, while the 60-day high of 293.72 presents a significant resistance point. Given this context, a potential trade plan is as follows: Suggested Entry: $268.50, slightly above the last close to confirm upward momentum. Stop Loss: $262.00, below the recent support level. Target 1: $275.00, near the 30-day MA. Target 2: $280.00, a psychological level before reaching the 50-day MA. This plan capitalizes on potential recovery while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:12 AM
$LH is currently trading at $267.35, with an RSI of 40.15 indicating it is approaching oversold territory, suggesting potential for upward movement. The price is below both the 30-day MA of 271.07 and the 50-day MA of 273.81, indicating a bearish short-term trend. However, the proximity to the 60-day low of 244.52 suggests a strong support level, while the 60-day high of 293.72 presents a significant resistance point. Given this context, a potential trade plan is as follows: Suggested Entry: $268.50, slightly above the last close to confirm upward momentum. Stop Loss: $262.00, below the recent support level. Target 1: $275.00, near the 30-day MA. Target 2: $280.00, a psychological level before reaching the 50-day MA. This plan capitalizes on potential recovery while managing risk effectively. https://privateprofiteers.com
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 7:55 PM
JP Morgan updates rating for Labcorp Hldgs ( $LH ) to Overweight, target set at 291 → 317.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 4 at 3:24 PM
$LH Share Price: $253.91 Contract Selected: May 15, 2026 $250 Calls Buy Zone: $18.45 – $22.79 Target Zone: $30.26 – $36.98 Potential Upside: 55% ROI Time to Expiration: 191 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
allen02
allen02 Nov. 4 at 12:14 PM
$LH Bullish Three White Soldiers Candlestick Pattern.
0 · Reply
Halo202
Halo202 Nov. 2 at 9:57 PM
$LH $260+ by Friday
0 · Reply
Nosh
Nosh Nov. 1 at 7:10 AM
$LH Yah coming in on Monday with a starter....
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 31 at 12:08 PM
$LH RSI: 30.29, MACD: -4.4495 Vol: 10.88, MA20: 276.54, MA50: 277.20 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 29 at 11:51 PM
$LH Share Price: $248.19 Contract Selected: May 15, 2026 $260 Calls Buy Zone: $11.05 – $13.65 Target Zone: $19.31 – $23.60 Potential Upside: 65% ROI Time to Expiration: 197 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BradHudson
BradHudson Oct. 29 at 6:54 PM
$LH Easy drop to $200 by EOY.....Trumpworld is crushing healthcare into the ground by mid 2026.
0 · Reply
Nikotime
Nikotime Oct. 29 at 4:58 PM
$LH one sec you're looking at a $300 challenge, the next sec it's diving towards $250 and looking to test the $240 range again
0 · Reply
Nosh
Nosh Oct. 29 at 3:35 AM
$LH Absolutely taking a slot in here tomorrow.
0 · Reply
Small_time_trader
Small_time_trader Oct. 28 at 8:43 PM
$LH DGX >> LH
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 28 at 6:27 PM
0 · Reply
profit_guru
profit_guru Oct. 28 at 2:51 PM
$LH - revenue guidance lowered due to currency fluctuations demand is strong across the board…might close green…imo
0 · Reply
profit_guru
profit_guru Oct. 28 at 2:47 PM
$LH - solid quarter and way oversold…expect strong reversal into close ….near term 300…imo
1 · Reply
Bazzzigar
Bazzzigar Oct. 28 at 12:24 PM
$LH join with DGX
0 · Reply
Estimize
Estimize Oct. 28 at 10:03 AM
$LH reported - EPS and - revenue for Q3. http://www.estimize.com/intro/lh?chart=historical&metric_name=eps&utm_content=LH&utm_medium=actual
0 · Reply
profit_guru
profit_guru Oct. 27 at 6:18 PM
$LH - new 52 wk high possible as more patients using lab services than ever before based insurance companies earnings results…near term 320…imo
0 · Reply